Publications

  1. Yost KJ, Cheville AL, Al-Hilli MM, Mariani A, Barrette BA, McGree ME, Weaver AL, Dowdy SC. Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol. 2014 Aug; 124(2 Pt 1):307-15.
    View PubMed
  2. AlHilli MM, Mariani A, Bakkum-Gamez JN, Dowdy SC, Weaver AL, Peethambaram PP, Keeney GL, Cliby WA, Podratz KC. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer. Gynecol Oncol. 2014 Jun; 133(3):485-93. Epub 2014 Mar 29.
    View PubMed
  3. Tabbaa ZM, Janco JM, Mariani A, Dowdy SC, McGree ME, Weaver AL, Cliby WA. Short-term outcomes after incontinent conduit for gynecologic cancer: comparison of ileal, sigmoid, and transverse colon. Gynecol Oncol. 2014 Jun; 133(3):563-7. Epub 2014 Apr 02.
    View PubMed
  4. Dowdy SC. Improving oncologic outcomes for women with endometrial cancer: realigning our sights. Gynecol Oncol. 2014 May; 133(2):370-4. Epub 2014 Feb 20.
    View PubMed
  5. Gonzalez-Bosquet J, Chu YL, Chen HB, Dowdy SC, Podratz KC, Li JP, Jiang SW. Development of an intracellular, dna methyltransferase-specific, and gene-specific assay for studying dynamic dna methylation. Curr Pharm Des. 2014 Apr; 20(11):1664-73.
  6. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Martin JR, Keeney GL, Jatoi A, Gostout BS, Podratz KC. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy. Gynecol Oncol. 2014 Mar; 132(3):578-84. Epub 2014 Jan 14.
    View PubMed
  7. Al-Wahab ZR, Kumar S, Mutch DG, Dowdy SC, Hensley SA, Wang Y, Mahdi H, Ali-Fehmi R, Morris RT, Elshaikh M, Munkarah AR. Racial disparities in uterine clear cell carcinoma: a multi-institution study. Int J Gynecol Cancer. 2014 Mar; 24(3):541-8.
    View PubMed
  8. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res. 2014 Feb; 40(2):301-11.
    View PubMed
  9. Bakkum-Gamez J, Dowdy S. Retooling the pap smear for ovarian and endometrial cancer detection. Clin Chem. 2014 Jan; 60(1):22-4. Epub 2013 Sep 16.
    View PubMed
  10. Kumar S, Podratz KC, Bakkum-Gamez JN, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Keeney GL, Thomas G, Mariani A. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. Gynecol Oncol. 2014 Jan; 132(1):38-43. Epub 2013 Oct 9
    View PubMed
  11. Warner LL, Dowdy SC, Martin JR, Lemens MA, McGree ME, Weaver AL, Podratz KC, Bakkum-Gamez JN. The impact of perioperative packed red blood cell transfusion on survival in epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Nov; 23(9):1612-9.
    View PubMed
  12. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, Cliby WA, Mariani A. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol. 2013 Oct; 131(1):103-8. Epub 2013 Jul 09.
    View PubMed
  13. Kumar S, Mariani A, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, Cliby WA, Podratz KC, Dowdy SC. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol. 2013 Sep; 130(3):441-5. Epub 2013 Jun 05.
    View PubMed
  14. Allensworth SK, Langstraat CL, Martin JR, Lemens MA, McGree ME, Weaver AL, Dowdy SC, Podratz KC, Bakkum-Gamez JN. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer. Gynecol Oncol. 2013 Sep; 130(3):499-504. Epub 2013 Jun 05.
    View PubMed
  15. Kalogera E, Bakkum-Gamez JN, Jankowski CJ, Trabuco E, Lovely JK, Dhanorker S, Grubbs PL, Weaver AL, Haas LR, Borah BJ, Bursiek AA, Walsh MT, Cliby WA, Dowdy SC. Enhanced recovery in gynecologic surgery. Obstet Gynecol. 2013 Aug; 122(2 Pt 1):319-28.
    View PubMed
  16. Kalogera E, Dowdy SC, Mariani A, Weaver AL, Aletti G, Bakkum-Gamez JN, Cliby WA. Multiple large bowel resections: potential risk factor for anastomotic leak. Gynecol Oncol. 2013 Jul; 130(1):213-8. Epub 2013 Apr 08.
    View PubMed
  17. Kumar S, Al-Wahab Z, Sarangi S, Woelk J, Morris R, Munkarah A, Dowdy SC, Mariani A, Cliby W. Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: a multi-institutional study. Gynecol Oncol. 2013 Jul; 130(1):207-12. Epub 2013 Apr 20.
    View PubMed
  18. Bakkum-Gamez JN, Dowdy SC, Borah BJ, Haas LR, Mariani A, Martin JR, Weaver AL, McGree ME, Cliby WA, Podratz KC. Predictors and costs of surgical site infections in patients with endometrial cancer. Gynecol Oncol. 2013 Jul; 130(1):100-6. Epub 2013 Apr 02.
    View PubMed
  19. Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Haddock MG, Keeney GL, Long HJ 3rd, Dowdy SC, Podratz KC. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecol Oncol. 2013 Jun; 129(3):478-85. Epub 2013 Mar 25.
    View PubMed
  20. Yost KJ, Cheville AL, Weaver AL, Al Hilli M, Dowdy SC. Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women. Phys Ther. 2013 May; 93(5):694-703. Epub 2013 Jan 03.
    View PubMed
  21. Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Klein KA, Haddock MG. Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer. Radiat Oncol. 2013 Apr 08; 8(1):80.
    View PubMed
  22. Fotopoulou C, Zang R, Gultekin M, Cibula D, Ayhan A, Liu D, Richter R, Braicu I, Mahner S, Harter P, Trillsch F, Kumar S, Peiretti M, Dowdy SC, Maggioni A, Trope C, Sehouli J. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation. Ann Surg Oncol. 2013 Apr; 20(4):1348-54. Epub 2012 Oct 2
    View PubMed
  23. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013 Feb; 128(2):294-9. Epub 2012 Oct 17.
    View PubMed
  24. Barney BM, Petersen IA, Mariani A, Dowdy SC, Bakkum-Gamez JN, Haddock MG. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):109-15. Epub 2012 Apr 28.
    View PubMed
  25. Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Alhilli MM, Martin JR, Keeney GL, Dowdy SC, Podratz KC. Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma. Gynecol Oncol. 2013 Jan; 128(1):71-6. Epub 2012 Nov 02.
    View PubMed
  26. Jiang SW, Chen H, Dowdy S, Fu A, Attewell J, Kalogera E, Drapkin R, Podratz K, Broaddus R, Li J. HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival. Int J Mol Sci. 2013; 14(11):22655-77. Epub 2013 Nov 18.
    View PubMed
  27. Mader EK, Butler G, Dowdy SC, Mariani A, Knutson KL, Federspiel MJ, Russell SJ, Galanis E, Dietz AB, Peng KW. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J Transl Med. 2013; 11:20. Epub 2013 Jan 24.
    View PubMed
  28. Alhilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Obstet Gynecol Surv. 2013; 68(3):199-200.
  29. Li J, Chen H, Mariani A, Chen D, Klatt E, Podratz K, Drapkin R, Broaddus R, Dowdy S, Jiang SW. HE4 (WFDC2) promotes tumor growth in endometrial cancer cell lines. Int. J. Mol. Sci. 2013; 14(3):6026-43.
  30. Getz G, Gabriel SB, Cibulskis K, Lander E, Sivachenko A, Sougnez C, Lawrence M, Kandoth C, Dooling D, Fulton R, Fulton L, Kalicki-Veizer J, McLellan MD, O'Laughlin M, Schmidt H, Wilson RK, Ye K, Li D, Ally A, Balasundaram M, Birol I, Butterfield YSN, Integrated genomic characterization of endometrial carcinoma. Nature. 2013; 497(7447):67-73.
  31. McMaster J, Dua A, Dowdy SC. Primary breast adenocarcinoma in ectopic breast tissue in the vulva. Case Rep Obstet Gynecol. 2013; 2013:721696. Epub 2013 Aug 26.
    View PubMed
  32. Bakkum-Gamez JN, Dowdy SC, Borah BJ, Haas LR, Mariani A, Martin JR, Weaver AL, McGree ME, Cliby WA, Podratz KC. Predictors and costs of surgical site infections in patients with endometrial cancer. Obstet Gynecol Surv. 2013; 68(8):567-8.
  33. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, Cliby WA, Mariani A. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012 Dec; 127(3):525-31. Epub 2012 Aug 29.
    View PubMed
  34. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Kumar S, Weaver AL, McGree ME, Haas LR, Cliby WA, Podratz KC. Factors predictive of postoperative morbidity and cost in patients with endometrial cancer. Obstet Gynecol. 2012 Dec; 120(6):1419-27.
    View PubMed
  35. Geels YP, Pijnenborg JM, van den Berg-van Erp SH, Bulten J, Visscher DW, Dowdy SC, Massuger LF. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis. Obstet Gynecol. 2012 Nov; 120(5):1124-31.
    View PubMed
  36. Torres ML, Weaver AL, Kumar S, Uccella S, Famuyide AO, Cliby WA, Dowdy SC, Gostout BS, Mariani A. Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol. 2012 Nov; 120(5):998-1004.
    View PubMed
  37. Allensworth S, Dowdy S, Martin J, Lemens M, McGree M, Weaver A, Podratz K, Bakkum-Gamez J. The prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S17-8.
    View PubMed
  38. Morgenstern L, Dowdy S, Martin J, Lemens M, McGree M, Weaver A, Podratz K, Bakkum-Gamez J. The impact of perioperative packed red blood cell transfusion on survival in epithelial ovarian cancer. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S27.
    View PubMed
  39. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A, Podratz KC. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol. 2012 Oct; 127(1):5-10. Epub 2012 Jul 03.
    View PubMed
  40. Bakkum-Gamez JN, Chien J, Clayton AC, Halling KC, Cliby WA, Dowdy SC, Kipp BR, Famuyide A, Mariani A, Oberg AL, Wentzensen N, Sherman M, Podratz KC, Shridhar V. Development of biomarkers in endometrial cancer and its precursor lesions. J Womens Health. 2012 Oct; 21(10):1004.
  41. Kalogera E, Dowdy SC, Mariani A, Aletti G, Bakkum-Gamez JN, Cliby WA. Utility of closed suction pelvic drains at time of large bowel resection for ovarian cancer. Gynecol Oncol. 2012 Sep; 126(3):391-6. Epub 2012 May 20.
    View PubMed
  42. Tolcher MC, Kalogera E, Hopkins MR, Weaver AL, Bingener J, Dowdy SC. Safety of culdotomy as a surgical approach: implications for natural orifice transluminal endoscopic surgery. JSLS. 2012 Jul-Sep; 16(3):413-20.
    View PubMed
  43. Bakkum-Gamez JN, Langstraat CL, Martin JR, Lemens MA, Weaver AL, Allensworth S, Dowdy SC, Cliby WA, Gostout BS, Podratz KC. Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma. Gynecol Oncol. 2012 Jun; 125(3):614-20. Epub 2012 Feb 24.
    View PubMed
  44. Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Haddock MG. Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma. Int J Radiat Oncol Biol Phys. 2012 May 1; 83(1):191-7. Epub 2011 Oct 08.
    View PubMed
  45. AlHilli MM, Dowdy SC, Weaver AL, St Sauver JL, Keeney GL, Mariani A, Podratz KC, Bakkum-Gamez JN. Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study. Gynecol Oncol. 2012 Apr; 125(1):109-13. Epub 2011 Dec 28.
    View PubMed
  46. Kalogera E, Scholler N, Powless C, Weaver A, Drapkin R, Li J, Jiang SW, Podratz K, Urban N, Dowdy SC. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. Gynecol Oncol. 2012 Feb; 124(2):270-5. Epub 2011 Oct 28.
    View PubMed
  47. Bakkum-Gamez JN, Kalogera E, Keeney GL, Mariani A, Podratz KC, Dowdy SC. Conservative management of atypical hyperplasia and grade i endometrial carcinoma: Review of the literature and presentation of a series. J Gynecol Surg. 2012; 28(4):262-9.
  48. Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Haddock MG. Intraoperative electron beam radiotherapy (IOERT) in the management of recurrent ovarian malignancies. Int J Gynecol Cancer. 2011 Oct; 21(7):1225-31.
    View PubMed
  49. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC. The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol. 2011 Oct; 123(1):58-64. Epub 2011 Jul 13.
    View PubMed
  50. Crane LM, van Oosten M, Pleijhuis RG, Motekallemi A, Dowdy SC, Cliby WA, van der Zee AG, van Dam GM. Intraoperative imaging in ovarian cancer: fact or fiction? Mol Imaging. 2011 Aug; 10(4):248-57. Epub 2011 Apr 26
    View PubMed
  51. Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, Hwa YL, Li J, Dowdy SC, Jiang SW. DNA hypermethylation as a chemotherapy target. Cell Signal. 2011 Jul; 23(7):1082-93. Epub 2011 Feb 21.
    View PubMed
  52. Mariani A, El-Nashar SA, Dowdy SC. Lymphadenectomy in endometrial cancer: which is the right question? Int J Gynecol Cancer. 2010 Oct; 20(11 Suppl 2):S52-4.
    View PubMed
  53. Singh BN, Zhang G, Hwa YL, Li J, Dowdy SC, Jiang SW. Nonhistone protein acetylation as cancer therapy targets. Expert Rev Anticancer Ther. 2010 Jun; 10(6):935-54.
    View PubMed
  54. Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1; 70(3):875-82. Epub 2010 Jan 26.
    View PubMed
  55. Mariani A, Cha SS, Bergstralh EJ, Boardman LA, Dowdy SC, Keeney GL, Podratz KC, Melton LJ 3rd. Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy. Eur J Gynaecol Oncol. 2010; 31(1):5-9.
    View PubMed
  56. Li J, Dowdy S, Tipton T, Podratz K, Lu WG, Xie X, Jiang SW. HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev Mol Diagn. 2009 Sep; 9(6):555-66.
    View PubMed
  57. Marnitz S, Dowdy S, Lanowska M, Schneider A, Podratz K, Kohler C. Exenterations 60 years after first description: results of a survey among US and German Gynecologic Oncology Centers. Int J Gynecol Cancer. 2009 Jul; 19(5):974-7.
    View PubMed
  58. Liu P, Khurana A, Rattan R, He X, Kalloger S, Dowdy S, Gilks B, Shridhar V. Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer. Cancer Res. 2009 Jun 1; 69(11):4843-50.
    View PubMed
  59. Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet. 2009 May; 105(2):110-1. Epub 2009 Mar 14.
    View PubMed
  60. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope RC, Wilson TO, Podratz KC, Cliby WA. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. J Am Coll Surg. 2009 Apr; 208(4):614-20.
    View PubMed
  61. Thomas MB, Keeney GL, Podratz KC, Dowdy SC. Endometrial stromal sarcoma: treatment and patterns of recurrence. Int J Gynecol Cancer. 2009 Feb; 19(2):253-6.
    View PubMed
  62. Konecny GE, Santos L, Winterhoff B, Hatmal M, Keeney GL, Mariani A, Jones M, Neuper C, Thomas B, Muderspach L, Riehle D, Wang HJ, Dowdy S, Podratz KC, Press MF. HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer. Br J Cancer. 2009 Jan 13; 100(1):89-95. Epub 2008 Dec 16.
    View PubMed
  63. Mariani A, Dowdy S, Podratz K. Views and counter views. The role of pelvic and para-aortic lymph node dissection in the surgical treatment of endometrial cancer: A view from the USA The Obstetrician and Gynaecologist. 2009; 11(3):199-204.
  64. Winterhoff BJ, Bakkum-Gamez JN, Mariani A, Dowdy SC. Special cases of endometrial carcinoma : FFertility retention and prevention in high-risk patients. [German]. Onkologe. 2009; 15(9):904-11.
  65. Uccella S, Dowdy SC, Mariani A. Disease-oriented individual postoperative therapy for female patients with endometrial cancinoma. [German]. Onkologe. 2009; 15(9):877-84.
  66. Dowdy SC, Aletti G, Cliby WA, Podratz KC, Mariani A. Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol. 2008 Dec; 111(3):418-24. Epub 2008 Oct 02.
    View PubMed
  67. Dozois EJ, Larson DW, Dowdy SC, Poola VP, Holubar SD, Cima RR. Transvaginal colonic extraction following combined hysterectomy and laparoscopic total colectomy: a natural orifice approach. Tech Coloproctol. 2008 Sep; 12(3):251-4. Epub 2008 Aug 05.
    View PubMed
  68. Jiang SW, Li J, Podratz K, Dowdy S. Application of DNA methylation biomarkers for endometrial cancer management. Expert Rev Mol Diagn. 2008 Sep; 8(5):607-16.
    View PubMed
  69. Thomas MB, Wright JD, Leiser AL, Chi DS, Mutch DG, Podratz KC, Dowdy SC. Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era. Gynecol Oncol. 2008 Jun; 109(3):335-9. Epub 2008 Apr 03.
    View PubMed
  70. Dowdy SC, Loewen RT, Aletti G, Feitoza SS, Cliby W. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. Gynecol Oncol. 2008 May; 109(2):303-7. Epub 2008 Apr 01.
    View PubMed
  71. Konecny GE, Agarwal R, Keeney GA, Winterhoff B, Jones MB, Mariani A, Riehle D, Neuper C, Dowdy SC, Wang HJ, Morin PJ, Podratz KC. Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Gynecol Oncol. 2008 May; 109(2):263-9. Epub 2008 Mar 07.
    View PubMed
  72. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008 Apr; 109(1):11-8. Epub 2008 Mar 04.
    View PubMed
  73. Thomas M, Mariani A, Wright JD, Madarek EO, Powell MA, Mutch DG, Podratz KC, Dowdy SC. Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review. Gynecol Oncol. 2008 Feb; 108(2):293-7. Epub 2007 Dec 21.
    View PubMed
  74. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008 Jan; 83(1):97-112.
    View PubMed
  75. Mariani A, Dowdy S, Podratz K. Surgical Treatment of Endometrial Cancer: the Role of Pelvic and Para-aortic Lymph Node Dissection (A View from the USA). The Obstetrician & Gynaecologist 2008. Epub In press.
  76. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 2007 Dec; 197(6):676.e1-7.
    View PubMed
  77. Dowdy SC, Mariani A, Bakkum JN, Cliby WA, Keeney GL, Podratz KC. Treatment of pulmonary recurrences in patients with endometrial cancer. Gynecol Oncol. 2007 Nov; 107(2):242-7. Epub 2007 Sep 17.
    View PubMed
  78. Thomas MB, Mariani A, Cliby WA, Keeney GL, Podratz KC, Dowdy SC. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol. 2007 Nov; 107(2):190-3. Epub 2007 Sep 06.
    View PubMed
  79. Thomas MB, Mariani A, Cliby WA, Keeney GA, Podratz KC, Dowdy SC. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007 Nov; 107(2):186-9. Epub 2007 Aug 3.
    View PubMed
  80. Zhou XC, Dowdy SC, Podratz KC, Jiang SW. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment. Gynecol Oncol. 2007 Oct; 107(1):143-53. Epub 2007 Aug 13.
    View PubMed
  81. Jiang S, Dowdy SC, Meng XW, Wang ZY, Jones MB, Podratz KC, Jiang SW. Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Gynecol Oncol. 2007 May; 105(2):493-500.
    View PubMed
  82. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol. 2007 Apr; 105(1):84-9.
    View PubMed
  83. Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, Weaver JP, Gabbay M, Ngo M, Lentz S, Cass I, Li AJ, Karlan BY, Holschneider CH. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol. 2007 Feb 1; 25(4):384-9.
    View PubMed
  84. Aletti GD, Dowdy S, Podratz KC, Cliby WA. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol. 2006 Dec; 195(6):1862-8.
    View PubMed
  85. Dowdy SC, Jiang S, Zhou XC, Hou X, Jin F, Podratz KC, Jiang SW. Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. Mol Cancer Ther. 2006 Nov; 5(11):2767-76.
    View PubMed
  86. Xiong Y, Dowdy SC, Eberhardt NL, Podratz KC, Jiang SW. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications. Gynecol Oncol. 2006 Oct; 103(1):321-8. Epub 2006 May 15.
    View PubMed
  87. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol. 2006 May; 101(2):200-8. Epub 2006 Feb 28.
    View PubMed
  88. Dowdy SC, Mariani A, Cliby WA, Haddock MG, Petersen IA, Sim FH, Podratz KC. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol. 2006 May; 101(2):280-6.
    View PubMed
  89. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol. 2006 Feb; 100(2):283-7. Epub 2005 Sep 22.
    View PubMed
  90. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006 Jan; 107(1):77-85.
    View PubMed
  91. Mariani A, Dowdy SC, Podratz KC. Outcomes of pulmonary failures in women with endometrial cancer. Gynecol Oncol Manuscript in progress. 2006.
  92. Xiong Y, Dowdy SC, Gonzalez Bosquet J, Zhao Y, Eberhardt NL, Podratz KC, Jiang SW. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. Gynecol Oncol. 2005 Oct; 99(1):135-41.
    View PubMed
  93. Dowdy SC, Gostout BS, Shridhar V, Wu X, Smith DI, Podratz KC, Jiang SW. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. Gynecol Oncol. 2005 Oct; 99(1):126-34.
    View PubMed
  94. Mariani A, Sebo TJ, Katzmann JA, Riehle DL, Dowdy SC, Keeney GL, Lesnick TG, Podratz KC. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature. Anticancer Res. 2005 Jul-Aug; 25(4):2921-7.
    View PubMed
  95. Mariani A, Dowdy SC, Keeney GL, Haddock MG, Lesnick TG, Podratz KC. Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol. 2005 Jun; 97(3):820-7.
    View PubMed
  96. Xiong Y, Dowdy SC, Podratz KC, Jin F, Attewell JR, Eberhardt NL, Jiang SW. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. Cancer Res. 2005 Apr 1; 65(7):2684-9.
    View PubMed
  97. Xiong YN, Dowdy SC, Xue AL, Jiang SJ, Eberhardt NL, Podratz KC, Jiang SW. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Gynecol Oncol. 2005 Mar; 96(3):601-9.
    View PubMed
  98. Dowdy SC, Mariani A, Reinholz MM, Keeney GL, Spelsberg TC, Podratz KC, Janknecht R. Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer. Gynecol Oncol. 2005 Feb; 96(2):368-73.
    View PubMed
  99. Dowdy SC, Metzinger DS, Gebhart JB, Srivatsa P, Haddock MG, Suman VJ, Podratz KC. Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer. Gynecol Oncol. 2005 Feb; 96(2):389-94.
    View PubMed
  100. Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC, Jiang SW. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. Gynecol Oncol. 2005 Feb; 96(2):531-8.
    View PubMed
  101. Mariani A, Dowdy SC, Keeney GL, Long HJ, Lesnick TG, Podratz KC. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol. 2004 Oct; 95(1):120-6.
    View PubMed
  102. Dowdy SC, Stefanek M, Hartmann LC. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol. 2004 Oct; 191(4):1113-23.
    View PubMed
  103. Cliby W, Dowdy S, Feitoza SS, Gostout BS, Podratz KC. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol. 2004 Sep; 94(3):655-60.
    View PubMed
  104. Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer. 2004 Jul 15; 101(2):346-52.
    View PubMed
  105. Dowdy SC, Constantinou CL, Hartmann LC, Keeney GL, Suman VJ, Hillman DW, Podratz KC. Long-term follow-up of women with ovarian cancer after positive second-look laparotomy. Gynecol Oncol. 2003 Dec; 91(3):563-8.
    View PubMed
  106. Dowdy SC, Mariani A, Janknecht R. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81. J Biol Chem. 2003 Nov 7; 278(45):44377-84. Epub 2003 Aug 28.
    View PubMed
  107. Dowdy SC, Cliby WA. Preparing for the unexpected: encountering gynecologic problems when operating for colon cancer. Current Surgery. 2003 Jan; 60(1):12-16.
    View PubMed
  108. Dowdy SC, Boardman CH, Wilson TO, Podratz KC, Hartmann LC, Long HJ. Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer. Am J Obstet Gynecol. 2002 Jun; 186(6):1167-73.
    View PubMed
  109. Dowdy SC, O'Kane DJ, Keeney GL, Boyd J, Podratz KC. Telomerase activity in sex cord-stromal tumors of the ovary. Gynecol Oncol. 2001 Aug; 82(2):257-60.
    View PubMed
  110. Dowdy SC, Pfeifer EA, Longcope DC, Cliby WA. Unusual recurrence of ovarian carcinoma 9 years after initial diagnosis. Gynecol Oncol. 1999 Sep; 74(3):495-8.
    View PubMed